Co-delivery of pEGFP-hTRAIL and paclitaxel to brain glioma mediated by an angiopep-conjugated liposome

Biomaterials

Volumn 33, Issue 3, 2012, Pages 916-924

  Sun, Xiyang ^a,b   Pang, Zhiqing ^a,b   Ye, Hongxing ^c   Qiu, Bo ^d   Guo, Liangran ^a,b   Li, Jingwei ^a,b   Ren, Jinfeng ^a,b   Qian, Yong ^a,b   Zhang, Qizhi ^a,b   Chen, Jun ^a,b   Jiang, Xinguo ^a,b  

^a FUDAN UNIVERSITY   (China)

^b BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

^c FUDAN UNIVERSITY   (China)

^d CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Brain glioma; Co delivery; Dual targeting; Paclitaxel; PEGFP hTRAIL

Indexed keywords

CATIONIC LIPOSOMES; CO-DELIVERY; DUAL TARGETING; GLIOMA CELLS; IN-VITRO; MEDIAN SURVIVAL; PACLITAXEL; PEGFP-HTRAIL; TEMOZOLOMIDE; THERAPEUTIC GENES;

CELL DEATH; DRUG DELIVERY; GENE ENCODING; GENE EXPRESSION; GENE THERAPY; MAMMALS;

TUMORS;

PACLITAXEL; TEMOZOLOMIDE; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; CELL STRAIN; CONTROLLED STUDY; GENE EXPRESSION; GENE TARGETING; GLIOMA; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; BRAIN NEOPLASMS; CELL LINE, TUMOR; GLIOMA; HUMANS; LIPOSOMES; MICE; MICE, INBRED BALB C; MICROSCOPY, ATOMIC FORCE; PACLITAXEL; PEPTIDES; TNF-RELATED APOPTOSIS-INDUCING LIGAND;

MUS;

EID: 81155131290     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2011.10.035     Document Type: Article

References (27)

1. Duesberg P., Li R., Sachs R., Fabarius A., Upender M.B., Hehlmann R. Cancer drug resistance: the central role of the karyotype. Drug Resist Updat 2007, 10(1-2):51-58.
2. Wang Y., Gao S., Ye W.H., Yoon H.S., Yang Y.Y. Co-delivery of drugs and DNA from cationic core-shell nanoparticles self-assembled from a biodegradable copolymer. Nat Mater 2006, 5(10):791-796.
3. Wiradharma N., Tong Y.W., Yang Y.Y. Self-assembled oligopeptide nanostructures for co-delivery of drug and gene with synergistic therapeutic effect. Biomaterials 2009, 30(17):3100-3109.
4. Wang S., El-Deiry W.S. TRAIL and apoptosis induction by TNF-family death receptors. Oncogene 2003, 22(53):8628-8633.
5. Hawkins C.J. TRAIL and malignant glioma. Vitam Horm 2004, 67:427-452.
6. Mora R., Abschuetz A., Kees T., Dokic I., Joschko N., Kleber S., et al. TNF-alpha- and TRAIL-resistant glioma cells undergo autophagy-dependent cell death induced by activated microglia. Glia 2009, 57(5):561-581.
7. Wu X.X., Ogawa O., Kakehi Y. TRAIL and chemotherapeutic drugs in cancer therapy. Vitam Horm 2004, 67:365-383.
8. Dorsey J.F., Mintz A., Tian X., Dowling M.L., Plastaras J.P., Dicker D.T., et al. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and paclitaxel have cooperative in vivo effects against glioblastoma multiforme cells. Mol Cancer Ther 2009, 8(12):3285-3295.
9. Walczak H., Miller R.E., Ariail K., Gliniak B., Griffith T.S., Kubin M., et al. Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo. Nat Med 1999, 5(2):157-163.
10. Jain R.K., di Tomaso E., Duda D.G., Loeffler J.S., Sorensen A.G., Batchelor T.T. Angiogenesis in brain tumours. Nat Rev Neurosci 2007, 8(8):610-622.
11. Juillerat-Jeanneret L. The targeted delivery of cancer drugs across the blood-brain barrier: chemical modifications of drugs or drug-nanoparticles?. Drug Discov Today 2008, 13(23-24):1099-1106.
12. Yoshida J., Mizuno M. Clinical gene therapy for brain tumors. Liposomal delivery of anticancer molecule to glioma. J Neurooncol 2003, 65(3):261-267.
13. Han L., Huang R., Li J., Liu S., Huang S., Jiang C. Plasmid pORF-hTRAIL and doxorubicin co-delivery targeting to tumor using peptide-conjugated polyamidoamine dendrimer. Biomaterials 2011, 32(4):1242-1252.
14. Zhu C., Jung S., Luo S., Meng F., Zhu X., Park T.G., et al. Co-delivery of siRNA and paclitaxel into cancer cells by biodegradable cationic micelles based on PDMAEMA-PCL-PDMAEMA triblock copolymers. Biomaterials 2010, 31(8):2408-2416.
15. Bagalkot V., Lee I.H., Yu M.K., Lee E., Park S., Lee J.H., et al. A combined chemoimmunotherapy approach using a plasmid-doxorubicin complex. Mol Pharm 2009, 6(3):1019-1028.
16. Saito R., Bringas J.R., Panner A., Tamas M., Pieper R.O., Berger M.S., et al. Convection-enhanced delivery of tumor necrosis factor-related apoptosis-inducing ligand with systemic administration of temozolomide prolongs survival in an intracranial glioblastoma xenograft model. Cancer Res 2004, 64(19):6858-6862.
17. Liu F., Shollenberger L.M., Huang L. Non-immunostimulatory nonviral vectors. FASEB J 2004, 18(14):1779-1781.
18. Ewert K.K., Ahmad A., Bouxsein N.F., Evans H.M., Safinya C.R. Non-viral gene delivery with cationic liposome-DNA complexes. Methods Mol Biol 2008, 433:159-175.
19. Ke W., Shao K., Huang R., Han L., Liu Y., Li J., et al. Gene delivery targeted to the brain using an Angiopep-conjugated polyethyleneglycol-modified polyamidoamine dendrimer. Biomaterials 2009, 30(36):6976-6985.
20. Regina A., Demeule M., Che C., Lavallee I., Poirier J., Gabathuler R., et al. Antitumour activity of ANG1005, a conjugate between paclitaxel and the new brain delivery vector Angiopep-2. Br J Pharmacol 2008, 155(2):185-197.
21. Xin H., Jiang X., Gu J., Sha X., Chen L., Law K., et al. Angiopep-conjugated poly(ethylene glycol)-co-poly(epsilon-caprolactone) nanoparticles as dual-targeting drug delivery system for brain glioma. Biomaterials 2011, 32(18):4293-4305.
22. Bellavance M.A., Poirier M.B., Fortin D. Uptake and intracellular release kinetics of liposome formulations in glioma cells. Int J Pharm 2010, 395(1-2):251-259.
23. Xin H., Chen L., Gu J., Ren X., Wei Z., Luo J., et al. Enhanced anti-glioblastoma efficacy by PTX-loaded PEGylated poly(varepsilon-caprolactone) nanoparticles: in vitro and in vivo evaluation. Int J Pharm 2010, 402(1-2):238-247.
24. Kuhlmann C.R., Lessmann V., Luhmann H.J. Fluvastatin stabilizes the blood-brain barrier in vitro by nitric oxide-dependent dephosphorylation of myosin light chains. Neuropharmacology 2006, 51(4):907-913.
25. Kim M., Liao J., Dowling M.L., Voong K.R., Parker S.E., Wang S., et al. TRAIL inactivates the mitotic checkpoint and potentiates death induced by microtubule-targeting agents in human cancer cells. Cancer Res 2008, 68(9):3440-3449.
26. Kagawa S., He C., Gu J., Koch P., Rha S.J., Roth J.A., et al. Antitumor activity and bystander effects of the tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) gene. Cancer Res 2001, 61(8):3330-3338.
27. Huang S., Li J., Han L., Liu S., Ma H., Huang R., et al. Dual targeting effect of Angiopep-2-modified, DNA-loaded nanoparticles for glioma. Biomaterials 2011, 32(28):6832-6838.